Oil adjuvant elevates protection of rainbow trout (Oncorhynchus mykiss) following injection
vaccination against Yersinia ruckeri
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Abstract
Enteric redmouth disease (ERM) caused by the fish pathogen Yersinia ruckeri is a major threat to freshwater
production of rainbow trout throughout all life stages. Injection vaccination of rainbow trout
against Y. ruckeri infection has been shown to confer better protection compared to the traditionally applied
immersion vaccination. It may be hypothesized, based on experience from other vaccines, that adjuvants may
increase the protective level of ERM injection vaccines even more. Controlled comparative vaccination
studies conducted to investigate effects of the oil adjuvant Montanide™ ISA 763 A VG when added to an
experimental Y. ruckeri bacterin (containing both biotype 1 and 2 of serotype O1). A total of 1000 fish with
mean weight 19 g was divided into five different groups (in duplicated tanks 2 × 100 fish per group) 1) nonvaccinated control fish (NonVac), 2) fish injected with a commercial vaccine (AquaVac ® Relera™)
(ComVac), 3) fish injected with an experimental vaccine (ExpVac), 4) fish injected with an experimental
vaccine + adjuvant (ExpVacAdj) and 5) fish injected with adjuvant alone (Adj). Injection of the experimental
vaccine (both adjuvanted and non-adjuvanted) induced a significantly higher antibody (IgM) level, increased
occurrence of IgM+ cells in spleen tissue and significant up-regulation of several immune genes. Additional
experiments using a higher challenge dosage suggested an immune enhancing effect of the adjuvant as the
challenge produced 100% mortality in the NonVac group, 60% mortality in both of ComVac and Adj groups
and only 13 and 2.5% mortalities in the ExpVac and the ExpVacAdj groups, respectively.
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